Suzumura A, Silberberg D H
Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia 19104.
Brain Res. 1989 Feb 20;480(1-2):51-7. doi: 10.1016/0006-8993(89)91565-5.
As oligodendrocytes develop in vitro, A2B5+ progenitor cells acquire the oligodendrocyte-specific marker, galactocerebroside (GalC), to become A2B5+ GalC+ cells. They then gradually lose reactivity to A2B5, to become A2B5- GalC+ mature oligodendrocytes. By examining this developmental surface antigen expression with and without lymphokine stimuli we found that crude lymphokines, but not interleukin-2 or gamma-interferon, facilitate this maturation process. Thus, lymphokines may have a role in differentiation of oligodendrocytes. The same lymphokine stimuli, however, did not enhance the proliferation of oligodendrocytes.
在体外培养少突胶质细胞时,A2B5 +祖细胞获得少突胶质细胞特异性标志物半乳糖脑苷脂(GalC),成为A2B5 + GalC +细胞。然后它们逐渐失去对A2B5的反应性,成为A2B5 - GalC +成熟少突胶质细胞。通过检测有无淋巴因子刺激时这种发育性表面抗原的表达,我们发现粗制淋巴因子而非白细胞介素-2或γ-干扰素可促进这一成熟过程。因此,淋巴因子可能在少突胶质细胞的分化中起作用。然而,相同的淋巴因子刺激并未增强少突胶质细胞的增殖。